drugset / Trial / NCT03513250
Efficacy of Hyoscine-n-butylbromide in Catheter-related Bladder Discomfort After Elective Cesarean Section.
RandomizedParallel-groupQuadruple-blindPrevention
Summary
a prospective, randomized, placebo-controlled study will be conducted to investigate whether hyoscine-n-butylbromide has preventive effects on early postoperative CRBD in patients with urinary catheters who will undergo elective cesarean sections.
Timeline
- Start
- 2018-05-30
- Primary completion
- 2020-07-01
- Completion
- 2020-07-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyoscine butylbromide | Unknown | 20 mg | Intravenous |